Skip to content

Balchem

US · BCPC #2068 by market cap Listed 1970
166.41 +1.12 +0.68%
Live - 5344 symbols - heartbeat 228s ago · 2026-10-07 19:54
After-hours 166.41 0.00%
Market cap
5.30B
P/B
4.07
EPS
4.75
Reader sentiment Are you bullish or bearish on BCPC?

Anonymous reader poll. Unscientific, not investment advice.

Analyst consensus 1 analysts

Buy
Avg price target 215.00 +29.2%
Price target rangecurrent 166.41
Low215.00
Avg215.00
High215.00
Buy 100% Hold 0% Sell 0%
Recent ratings (6)
DateFirmAnalystRatingTarget
2026-08-03 H.C. Wainwright -- BUY 215.00
2026-05-04 Sidoti -- BUY 234.00
2026-05-04 H.C. Wainwright -- BUY 190.00
2026-02-24 H.C. Wainwright -- BUY 190.00
2025-12-05 Rothschild & Co Redburn -- HOLD 162.00
2025-10-22 H.C. Wainwright -- BUY 190.00

Quant vs Street three independent views, side by side

Momentum strategy signal
Sell
Analyst consensus
Buy

Signals diverge - worth digging into why.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q2 2026-07-31 -- ±5.80% +2.97% (in line)
2026/Q1 2026-04-30 -- ±4.34% -6.76% (beat)
2025/Q4 2026-02-20 -- ±5.36% -2.11% (in line)
2025/Q3 2025-10-21 -- ±4.67% +4.06% (in line)
2025/Q2 2025-07-31 -- ±15.47% +0.25% (in line)
2025/Q1 2025-04-24 -- ±9.18% -2.60% (in line)
2024/Q4 2025-02-21 -- ±8.88% +1.48% (in line)
2024/Q3 2024-10-25 -- -- +3.19%
2024/Q2 2024-07-26 -- ±8.37% +3.42% (in line)
2024/Q1 2024-05-03 -- -- +2.82%
2023/Q4 2024-02-16 -- ±6.76% +1.92% (in line)
2023/Q3 2023-10-27 -- -- -5.42%

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.